Diversity and Inclusion in Pediatric Infectious Diseases

Friday, April 25, 2025

9:20am – 9:55am HST

Location: Convention Center: 313 A

Chair(s)

AF

Anthony R. Flores, MD, MPH, PhD (he/him/his)
Professor
Vanderbilt University Medical Center
Nashville, Tennessee, United States

Speaker(s)

Natascha Ching, MD, FAAP (she/her/hers)
Associate Professor of Pediatrics
University of Hawaii, John A. Burns School of Medicine, Kapiolani Medical Center for Women & Children
Honolulu, Hawaii, United States
Sabina Holland, MD (she/her/hers)
Assistant Dean of Medicine, PLME FURM
The Warren Alpert Medical School of Brown University, United States
DN

Delma J. Nieves, MD (she/her/hers)
Associate Clinical Professor
UC, Irvine and CHOC Children's Hospital
Orange, California, United States
Elijah Paintsil, MD
The Joel & Barbara Alpert Professor and Chair Department of Pediatrics
Boston University Chobanian & Avedisian School of Medicine
Boston, Massachusetts, United States

Disclosure(s):

Anthony R. Flores, MD, MPH, PhD: GlycosBio, Inc. (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

Natascha Ching, MD, FAAP: Abbvie Inc (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Bristol Myers Squibb (Terminated, October 9, 2023) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Eli Lily & Co (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Hawaii American Academy of Pediatrics - Project Firstline (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Johnson & Johnson (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Merck (Terminated, October 9, 2023) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Organon (Terminated, October 10, 2024) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Pfizer (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)

Sabina Holland, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Delma J. Nieves, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Elijah Paintsil, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.